Scand J Child Adolesc Psychiatr Psychol. 2016 May;4(2):96-104. doi: 10.21307/sjcapp-2016-014.
Behavioral Weight Loss Treatment in Antipsychotic Treated Youth.
Scandinavian journal of child and adolescent psychiatry and psychology
Ginger E Nicol, Rachel P Kolko, Monica Mills, Thrudur Gunnarsdottir, Michael D Yingling, Julia A Schweiger, Eric J Lenze, John W Newcomer, Denise Wilfley
Affiliations
Affiliations
- Healthy Mind Lab, Department of Psychiatry, Washington University School of Medicine, St. Louis MO.
- Department of Psychiatry, Western Psychiatric Institute, University of Pittsburgh Medical Center, Pittsburgh, PA.
- Department of Psychology, University of Akureyri, Iceland.
- Weight Management & Eating Disorders Program, Department of Psychiatry, Washington University School of Medicine, St. Louis MO.
- Weight Management & Eating Disorders Program, Department of Psychiatry, Washington University School of Medicine, St. Louis MO; Department of Psychology, Washington University School of Medicine, St. Louis, MO; Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO; Department of Pediatrics, Washington University School of Medicine, St. Louis MO.
PMID: 27347489
PMCID: PMC4916921 DOI: 10.21307/sjcapp-2016-014
Abstract
BACKGROUND: Antipsychotic-treated youth have increased risk for the development of obesity and type 2 diabetes. Behavioral weight loss treatments show promise in reducing obesity and diabetes risk in antipsychotic treated adults, but have received no study in antipsychotic treated youth.
OBJECTIVE: We describe a rationale for behavioral weight loss interventions in high-weight antipsychotic treated youth, and report behavioral, anthropomorphic, and metabolic findings from a case series of obese antipsychotic-treated adolescents participating in a short-term, family-based behavioral weight loss intervention.
METHODS: We adapted the Traffic Light Plan, a 16-week family-based weight loss intervention that promotes healthy energy balance using the colors of the traffic light to categorize the nutritional value of foods and intensity of physical activity, adapting a social ecological framework to address health behavior change in multiple social contexts. The intervention was administered to three obese adolescents with long-term antipsychotic medication exposure. Efficacy of the intervention was evaluated with a battery of anthropomorphic and metabolic assessments including weight, body mass index percentile, whole body adiposity, liver fat content, and fasting plasma glucose and lipids. Participants and their parents also filled out a treatment satisfaction questionnaire upon study completion.
RESULTS: Two males and 1 female (all aged 14 years) participated. All 3 participants attended all 16 sessions, and experienced beneficial changes in adiposity, fasting lipids and liver fat content associated with weight stabilization or weight loss. Adolescents and their parents all reported a high level of satisfaction with the treatment.
CONCLUSIONS: Family-based behavioral weight loss treatment can be feasibly delivered and is acceptable to antipsychotic-treated youth and their families. Randomized controlled trials are needed to fully evaluate the effectiveness and acceptability of behavioral weight loss interventions in antipsychotic treated youth and their families.
Keywords: Antipsychotic; At-Risk Youth; Pediatric Obesity; Weight Loss Treatment
References
- Am J Clin Nutr. 2000 Aug;72(2 Suppl):521S-8S - PubMed
- Curr Psychiatry Rep. 2013 May;15(5):355 - PubMed
- Am Fam Physician. 2008 Jul 1;78(1):56-63 - PubMed
- Health Psychol. 2007 Sep;26(5):521-32 - PubMed
- Am J Community Psychol. 2009 Dec;44(3-4):316-26 - PubMed
- JAMA Intern Med. 2015 Aug;175(8):1412-3 - PubMed
- J Clin Psychiatry. 2007 Mar;68(3):e07 - PubMed
- Am J Psychiatry. 2006 Mar;163(3):402-10 - PubMed
- JAMA. 2009 Oct 28;302(16):1765-73 - PubMed
- JAMA Pediatr. 2013 Jan;167(1):21-6 - PubMed
- Adv Data. 2000 Jun 8;(314):1-27 - PubMed
- Am J Physiol. 1989 Mar;256(3 Pt 2):R605-11 - PubMed
- Prog Brain Res. 2000;126:325-41 - PubMed
- J Pediatr Psychol. 2014 Sep;39(8):809-25 - PubMed
- Psychiatr Serv. 2015 Apr 1;66(4):404-10 - PubMed
- Pediatrics. 2007 Dec;120 Suppl 4:S254-88 - PubMed
- Obesity (Silver Spring). 2008 Feb;16(2):318-26 - PubMed
- Am J Psychiatry. 2015 Jan;172(1):71-81 - PubMed
- J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44 - PubMed
- Arch Pediatr Adolesc Med. 2010 Apr;164(4):344-51 - PubMed
- Neuropsychopharmacology. 2003 Mar;28(3):519-26 - PubMed
- J Clin Psychiatry. 2007;68 Suppl 4:8-13 - PubMed
- J Pediatr. 2013 Mar;162(3):496-500.e1 - PubMed
- J Child Adolesc Psychopharmacol. 2009 Oct;19(5):563-73 - PubMed
- J Clin Psychopharmacol. 2012 Aug;32(4):458-64 - PubMed
- Pediatrics. 2007 Dec;120 Suppl 4:S164-92 - PubMed
- Circulation. 2013 Oct 8;128(15):1689-712 - PubMed
- Health Psychol. 2007 Jul;26(4):381-91 - PubMed
- Early Interv Psychiatry. 2012 Aug;6(3):347-53 - PubMed
- Health Psychol. 2004 Jul;23(4):371-80 - PubMed
- Exp Neurol. 2008 Jan;209(1):261-7 - PubMed
- N Engl J Med. 2013 Apr 25;368(17):1594-602 - PubMed
- Brain Res. 1988 Feb 16;441(1-2):403-7 - PubMed
- JAMA. 2007 Oct 10;298(14):1661-73 - PubMed
- Arch Pediatr Adolesc Med. 2000 Mar;154(3):220-6 - PubMed
- Pediatr Clin North Am. 2011 Dec;58(6):1403-24, x - PubMed
- Child Adolesc Psychiatry Ment Health. 2013 Aug 15;7(1):31 - PubMed
- J Pharmacol Exp Ther. 2000 Oct;295(1):226-32 - PubMed
- J Dev Behav Pediatr. 2008 Aug;29(4):276-84 - PubMed
- Am J Psychiatry. 2005 Jul;162(7):1361-9 - PubMed
- JAMA Psychiatry. 2015 Sep;72(9):867-74 - PubMed
- JAMA Psychiatry. 2013 Oct;70(10):1067-75 - PubMed
- J Consult Clin Psychol. 2014 Dec;82(6):1140-50 - PubMed
Publication Types
Grant support